Treatment of the Overactive Bladder Syndrome: A Delphi Study

Ghent University Hospital (UZ)

Status: Completed

Conditions: Overactive Bladder Syndrome

Treatments: Other: Delphi questionnaire

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT04300400

B670201835542

Details and patient eligibility

About

Idiopathic overactive bladder syndrome (iOAB) is a prevalent condition in urological practice. The variability in management between specialists and between centers remains high. Even guidelines are not always clear on the treatment management of drug therapy resistant OAB. Standardization in OAB treatment is needed.

Full description

Guidelines on the overactive bladder syndrome (European Association of Urology, American Urology Association and International Consultation on Incontinence) are comparable but remain vague mainly on the level between conservative and major surgery. They do not specify combinations of medications and do not distinguish between intradetrusor botulinum toxin injections (BTX) and sacral neuromodulation (SNM) because of lack of evidence.

To reduce the variability in the treatment management of OAB, standardization is needed.

By use of a Delphi technique, the current perception of Belgian urologists towards the most appropriate treatment approach for idiopathic OAB (iOAB) was explored.

Based on these results a practical treatment algorithm for its use in daily clinical practice could be developed.

Enrollment: 20 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Profession: MD, Urologist
• Member of the working group of Functional Urology

Exclusion criteria

• Retirement
• Non-operative as an urologist.

Trial design

20 participants in 1 patient group

Delphi panel

Description:

Urologists of the Belgian Working group of Functional Urology willing to participate on the Delphi project.

Treatment:

Other: Delphi questionnaire